English
TTK Healthcare Q2 Results
- BSE: 507747
- NSE: TTKHLTCARE
- ISIN: INE910C01018
- Sector: Biotechnology & Drugs
BSE
969.00
-13.05 (-1.33%)
-13.05 (-1.33%)Volume459.00
Updated: Fri 23 Jan, 2026 | 15:29:20
NSE
965.30-15.40 (-1.57%)
-15.40 (-1.57%)Volume4.68 K
Updated: Fri 23 Jan, 2026 | 15:47:31
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - TTK Healthcare Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 200.45 | 225.94 | -11.28% | 192.26 | 4.26% |
| Depreciation/ Amortization | 2.21 | 2.19 | 1.08% | 2.00 | 10.34% |
| Operating Income | 3.12 | 0.49 | 540.49% | 6.22 | -49.83% |
| Net Income | 20.39 | 13.00 | 56.83% | 17.20 | 18.52% |
| Other Operating Expenses Total | 59.27 | 80.60 | -26.46% | 62.69 | -5.45% |
| Net Income Before Taxes | 21.30 | 17.65 | 20.64% | 23.19 | -8.16% |
| Total Revenue | 203.57 | 226.43 | -10.10% | 198.49 | 2.56% |
| Selling/ General/ Admin Expenses Total | 41.11 | 41.33 | -0.54% | 37.72 | 8.98% |
| Diluted Normalized EPS | 14.43 | 9.20 | 56.85% | 12.17 | 18.57% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.